Insider · CIK 0001107486
Michael T Sember
Files at QNRX (Quoin Pharmaceuticals, Ltd.). First filing -, latest -.
Michael T Sember files SEC Form 4 as director at QNRX (Quoin Pharmaceuticals, Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael T Sember has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +8,141 | $0.00 | $0 | 8,141 | Feb 6, 2026 |
| May 29, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 2, 2025 |
| Dec 9, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
Questions about Michael T Sember
Answered from the filings on this page, as of the latest one.
Is Michael T Sember buying or selling?
Michael T Sember has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael T Sember's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael T Sember has 0.
Where does Michael T Sember file Form 4?
Michael T Sember has filed Form 4 at QNRX (Quoin Pharmaceuticals, Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.